샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513861

세계의 핵산 검사 시장

Nucleic Acid Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 372 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

핵산 검사 세계 시장은 2030년까지 44억 달러에 달할 전망

2023년 32억 달러로 추정되는 세계 핵산 검사 시장은 2023-2030년 동안 연평균 4.6% 성장하여 2030년에는 44억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 핵산 검사 키트는 CAGR 5.1%를 기록하여 분석 기간 종료 시점에 37억 달러에 도달할 것으로 예상됩니다. 핵산 검사 소모품 부문의 성장률은 분석 기간 동안 CAGR 1.8%로 추정됩니다.

미국 시장 8억 7,180만 달러, 중국은 CAGR 7.8%로 성장 전망

미국 핵산 검사 시장은 2023년 8억 7,180만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 7.8%의 CAGR로 2030년까지 9억 5,080만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 1.2%와 5.1%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 2.3%의 CAGR로 성장할 것으로 예상됩니다.

세계 핵산 검사 시장 - 주요 동향 및 촉진요인 요약

핵산 검사(NAT)는 시료에서 DNA 또는 RNA의 특정 염기서열을 검출하는 데 사용되는 첨단 생물학적 기술입니다. 이 방법은 의료 진단, 법의학, 생물학 연구 등 다양한 분야에서 필수적인 요소로 자리 잡았습니다. 핵산 검사(NAT)는 특히 의료 분야에서 다양한 진단 및 스크리닝 용도로 사용되는 중요한 분자 기술입니다. 혈액, 소변, 조직에 존재하는 바이러스, 박테리아 및 기타 병원체에서 DNA 또는 RNA의 특정 염기서열을 검출하기 위해 첨단 기법을 활용하고 있으며, NAT 시장의 주요 촉진요인 중 하나는 의료 진단에 대한 사용 증가입니다. 질병을 유발하는 바이러스나 박테리아 등의 병원체를 검출하는 고감도 방법을 기술하고 있습니다. 병원체에서 직접 유전 물질을 검출할 수 있기 때문에 배양 기술과 같은 기존 방법에 비해 더 빠르고 정확한 진단이 가능합니다. 이는 HIV, B형 간염, C형 간염, 결핵, COVID-19와 같은 감염성 질환의 진단에 특히 중요하며, 적시에 정확한 검출은 치료 결과와 환자의 회복에 큰 영향을 미칩니다.

기술의 발전은 이 검사법의 능력과 접근성을 향상시킴으로써 NAT 시장을 발전시키고 있습니다. 중합효소 연쇄 반응(PCR), 실시간 PCR, 차세대 염기서열분석(NGS)의 개선으로 NAT의 적용 범위가 넓어지고 더 빠르고 정확하며 비용 효율적인 검사법이 되었습니다. 또한, 휴대용 및 현장 진단용 NAT 기기의 개발로 즉각적인 진단이 가능해짐에 따라 이 기술의 도달 범위가 전통적인 실험실 환경에서 환자 치료 시나리오로 확장되고 있습니다. 이러한 기술 혁신은 개인의 유전자 프로파일에 따라 치료법을 조정하여 치료 효과와 환자 안전성을 향상시키는 개인 맞춤형 의료의 증가 추세를 뒷받침하고 있으며, NAT는 유전자형 분석, 약리유전체학, 암유전체학에서 매우 중요하며, 특정 치료법의 효과에 영향을 미칠 수 있는 유전자 변이를 식별하는 데 도움이 됩니다. 이러한 정확한 접근법은 치료 효과를 높이고 부작용을 최소화하며 환자 예후를 개선하는 데 도움이 됩니다.

유전자 검사, 법의학 분야에서의 NAT 적용 증가, 규제 기관 및 정부의 지원은 시장 성장을 더욱 촉진하고 있습니다. 미량의 유전물질을 검출하고 정량화할 수 있는 NAT의 능력은 유전자 연구 및 진단, 범죄 수사 및 재난 피해자 신원 확인과 같은 법의학 분야에서 매우 유용하게 활용되고 있습니다. 기술이 계속 발전함에 따라 정확하고 빠른 진단에 대한 수요가 NAT 시장의 성장을 주도하고 의료 및 과학 발전에 필수적인 역할을 할 것으로 예상됩니다.

조사 대상 기업 예시(46개사)

  • Abbott Molecular, Inc.
  • Beckman Coulter-Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.07.24

Global Nucleic Acid Testing Market to Reach US$4.4 Billion by 2030

The global market for Nucleic Acid Testing estimated at US$3.2 Billion in the year 2023, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Nucleic Acid Testing Consumables segment is estimated at 1.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$871.8 Million While China is Forecast to Grow at 7.8% CAGR

The Nucleic Acid Testing market in the U.S. is estimated at US$871.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$950.8 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Nucleic Acid Testing Market - Key Trends and Drivers Summarized

Nucleic Acid Testing (NAT) is a sophisticated biological technique used to detect specific sequences of DNA or RNA in a sample. This method has become indispensable in various fields, including medical diagnostics, forensic science, and biological research. Nucleic Acid Testing (NAT) is a vital molecular technique employed in various diagnostic and screening applications, particularly in the medical field. It utilizes advanced methodologies to detect the specific sequences of DNA or RNA from viruses, bacteria, or other pathogens present in blood, urine, or tissues. One of the primary drivers of the NAT market is its increasing use in medical diagnostics. NAT offers a highly sensitive method for detecting pathogens, including viruses and bacteria that cause diseases. Its ability to detect genetic material directly from pathogens enables earlier and more accurate diagnosis compared to traditional methods like culture techniques. This is particularly critical in the diagnosis of infectious diseases such as HIV, hepatitis B and C, tuberculosis, and COVID-19, where timely and precise detection can significantly influence treatment outcomes and patient recovery.

Technological advancements are propelling the NAT market forward by enhancing the capabilities and accessibility of this testing method. Improvements in polymerase chain reaction (PCR), real-time PCR, and next-generation sequencing (NGS) have broadened NAT's applications, making it faster, more accurate, and cost-effective. Additionally, the development of portable and point-of-care NAT devices allows for immediate diagnoses, extending the technology's reach beyond traditional lab settings into immediate patient care scenarios. These innovations support the growing trend toward personalized medicine, where treatments are tailored based on individual genetic profiles, improving treatment efficacy and patient safety. NAT is crucial in genotyping, pharmacogenomics, and cancer genomics, helping to identify genetic mutations that may influence the effectiveness of certain therapies. This precise approach enhances treatment efficacy and minimizes adverse drug reactions, leading to better patient outcomes.

The increasing application of NAT in genetic testing, forensic science, and the support of regulatory bodies and governments further boost market growth. NAT's ability to detect and quantify minute amounts of genetic material makes it invaluable in genetic research and diagnostics, as well as in forensic applications for identifying individuals in criminal investigations and disaster victim identification. As technology continues to evolve, the demand for precise and rapid diagnostics is expected to drive substantial growth in the NAT market, affirming its integral role in healthcare and scientific advancements.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Beckman Coulter - Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Nucleic Acid Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Infectious Diseases Drives Nucleic Acid Testing Market Growth
    • Technological Advancements in PCR and NGS Propel Market Expansion
    • Increasing Adoption in Clinical Diagnostics Expands Addressable Market
    • Rising Demand for Point-of-Care Testing Generates Market Opportunities
    • Expansion of Molecular Diagnostic Laboratories Accelerates Market Growth
    • Growing Focus on Early Disease Detection Sustains Market Growth
    • Increasing Use in Oncology and Cancer Research Spurs Market Adoption
    • Advances in CRISPR and Gene Editing Technologies Generate Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nucleic Acid Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Nucleic Acid Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Nucleic Acid Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Nucleic Acid Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제